The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...
Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting to profit booking.
The drugmaker hopes an Nvidia-chip powered supercomputer will help it find new drugs and accelerate lengthy R&D timelines.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback